These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 11456335)
1. Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing. Barber DS; Hunt JR; Ehrich MF; Lehning EJ; LoPachin RM Neurotoxicology; 2001 Jun; 22(3):341-53. PubMed ID: 11456335 [TBL] [Abstract][Full Text] [Related]
2. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord. Lehning EJ; Balaban CD; Ross JF; LoPachi RM Neurotoxicology; 2002 Sep; 23(3):415-29. PubMed ID: 12387367 [TBL] [Abstract][Full Text] [Related]
3. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord. Lehning EJ; Balaban CD; Ross JF; LoPachin RM Neurotoxicology; 2003 Jan; 24(1):109-23. PubMed ID: 12564387 [TBL] [Abstract][Full Text] [Related]
4. NTP-CERHR monograph on the potential human reproductive and developmental effects of acrylamide. National Toxicology Program NTP CERHR MON; 2005 Feb; (14):v-I-2, II-xi-166, III-1-74. PubMed ID: 15995732 [TBL] [Abstract][Full Text] [Related]
5. Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. Doerge DR; Young JF; McDaniel LP; Twaddle NC; Churchwell MI Toxicol Appl Pharmacol; 2005 Nov; 208(3):199-209. PubMed ID: 16239164 [TBL] [Abstract][Full Text] [Related]
6. Acrylamide disrupts elemental composition and water content of rat tibial nerve. III. Recovery. LoPachin RM; Lehning EJ; Castiglia CM; Saubermann AJ Toxicol Appl Pharmacol; 1993 Sep; 122(1):54-60. PubMed ID: 8378932 [TBL] [Abstract][Full Text] [Related]
7. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Bergmark E; Calleman CJ; Costa LG Toxicol Appl Pharmacol; 1991 Nov; 111(2):352-63. PubMed ID: 1957318 [TBL] [Abstract][Full Text] [Related]
9. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. Tareke E; Twaddle NC; McDaniel LP; Churchwell MI; Young JF; Doerge DR Toxicol Appl Pharmacol; 2006 Nov; 217(1):63-75. PubMed ID: 17007897 [TBL] [Abstract][Full Text] [Related]
10. Limited lactational transfer of acrylamide to rat offspring on maternal oral administration during the gestation and lactation periods. Takahashi M; Shibutani M; Nakahigashi J; Sakaguchi N; Inoue K; Morikawa T; Yoshida M; Nishikawa A Arch Toxicol; 2009 Aug; 83(8):785-93. PubMed ID: 19305978 [TBL] [Abstract][Full Text] [Related]
11. Acrylamide neuropathy. I. Spatiotemporal characteristics of nerve cell damage in rat cerebellum. Lehning EJ; Balaban CD; Ross JF; Reid MA; LoPachin RM Neurotoxicology; 2002 Sep; 23(3):397-414. PubMed ID: 12387366 [TBL] [Abstract][Full Text] [Related]
12. Nerve terminals as the primary site of acrylamide action: a hypothesis. LoPachin RM; Ross JF; Lehning EJ Neurotoxicology; 2002 May; 23(1):43-59. PubMed ID: 12164547 [TBL] [Abstract][Full Text] [Related]
13. Acrylamide neuropathy. III. Spatiotemporal characteristics of nerve cell damage in forebrain. Lehning EJ; Balaban CD; Ross JF; LoPachin RM Neurotoxicology; 2003 Jan; 24(1):125-36. PubMed ID: 12564388 [TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice. Doerge DR; Young JF; McDaniel LP; Twaddle NC; Churchwell MI Toxicol Appl Pharmacol; 2005 Feb; 202(3):258-67. PubMed ID: 15667831 [TBL] [Abstract][Full Text] [Related]
15. Effect of subchronic exposure to acrylamide induced on the expression of bcl-2, bax and caspase-3 in the rat nervous system. Li SX; Cui N; Zhang CL; Zhao XL; Yu SF; Xie KQ Toxicology; 2006 Jan; 217(1):46-53. PubMed ID: 16242231 [TBL] [Abstract][Full Text] [Related]
16. Acrylamide disrupts elemental composition and water content of rat tibial nerve. II. Schwann cells and myelin. LoPachin RM; Castiglia CM; Saubermann AJ Toxicol Appl Pharmacol; 1992 Jul; 115(1):35-43. PubMed ID: 1631891 [TBL] [Abstract][Full Text] [Related]
17. A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the rat. Kirman CR; Gargas ML; Deskin R; Tonner-Navarro L; Andersen ME J Toxicol Environ Health A; 2003 Feb; 66(3):253-74. PubMed ID: 12521671 [TBL] [Abstract][Full Text] [Related]
18. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. LoPachin RM; Ross JF; Reid ML; Das S; Mansukhani S; Lehning EJ Neurotoxicology; 2002 May; 23(1):95-110. PubMed ID: 12164553 [TBL] [Abstract][Full Text] [Related]
19. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444 [TBL] [Abstract][Full Text] [Related]
20. Subchronic toxicity and concomitant toxicokinetics of long-term oral administration of total alkaloid extracts from seeds of Peganum harmala Linn: A 28-day study in rats. Wang Y; Wang H; Zhang L; Zhang Y; Sheng Y; Deng G; Li S; Cao N; Guan H; Cheng X; Wang C J Ethnopharmacol; 2019 Jun; 238():111866. PubMed ID: 30970283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]